Home

La dracu Statistic topor bta sau nmp22 markeri pret Privilegiat marmora Document

Tumor M2-PK: A novel urine marker of bladder cancer | PLOS ONE
Tumor M2-PK: A novel urine marker of bladder cancer | PLOS ONE

Cancers | Free Full-Text | Noninvasive Urine-Based Tests to Diagnose or  Detect Recurrence of Bladder Cancer | HTML
Cancers | Free Full-Text | Noninvasive Urine-Based Tests to Diagnose or Detect Recurrence of Bladder Cancer | HTML

Influencing factors on the NMP-22 urine assay: an experimental model | BMC  Urology | Full Text
Influencing factors on the NMP-22 urine assay: an experimental model | BMC Urology | Full Text

Sensitivity and Specificity Analysis of Urine NMP22, Cytokeratin-18, CA  19-9 and Cytology, for Diagnosing Bladder Malignancy
Sensitivity and Specificity Analysis of Urine NMP22, Cytokeratin-18, CA 19-9 and Cytology, for Diagnosing Bladder Malignancy

Influencing factors on the NMP-22 urine assay: an experimental model | BMC  Urology | Full Text
Influencing factors on the NMP-22 urine assay: an experimental model | BMC Urology | Full Text

Internet Scientific Publications
Internet Scientific Publications

Prognostic urinary biomarkers for bladder cancer | Download Table
Prognostic urinary biomarkers for bladder cancer | Download Table

A Cost Comparison of the Diagnostic Modalities Used in the Detection of  Urothelial Carcinoma in Patients Undergoing Evaluation for Hematuria
A Cost Comparison of the Diagnostic Modalities Used in the Detection of Urothelial Carcinoma in Patients Undergoing Evaluation for Hematuria

JPM | Free Full-Text | Liquid Biopsy Biomarkers in Urine: A Route towards  Molecular Diagnosis and Personalized Medicine of Bladder Cancer | HTML
JPM | Free Full-Text | Liquid Biopsy Biomarkers in Urine: A Route towards Molecular Diagnosis and Personalized Medicine of Bladder Cancer | HTML

Molecular screening for bladder cancer: progress and potential | Nature  Reviews Urology
Molecular screening for bladder cancer: progress and potential | Nature Reviews Urology

Risk Stratification for Bladder Tumor Recurrence, Stage and Grade by  Urinary Nuclear Matrix Protein 22 and Cytology - European Urology
Risk Stratification for Bladder Tumor Recurrence, Stage and Grade by Urinary Nuclear Matrix Protein 22 and Cytology - European Urology

Bladder Cancer Markers and Recent Innovations | IntechOpen
Bladder Cancer Markers and Recent Innovations | IntechOpen

Molecular screening for bladder cancer: progress and potential | Nature  Reviews Urology
Molecular screening for bladder cancer: progress and potential | Nature Reviews Urology

Risk Stratification for Bladder Tumor Recurrence, Stage and Grade by  Urinary Nuclear Matrix Protein 22 and Cytology - European Urology
Risk Stratification for Bladder Tumor Recurrence, Stage and Grade by Urinary Nuclear Matrix Protein 22 and Cytology - European Urology

Analize medicale - Markeri tumorali | Bioclinica
Analize medicale - Markeri tumorali | Bioclinica

NMP 22 (marker tumoral vezică urinara) - Synevo
NMP 22 (marker tumoral vezică urinara) - Synevo

Internet Scientific Publications
Internet Scientific Publications

Clinical Urology: Original Articles | Journal of Urology
Clinical Urology: Original Articles | Journal of Urology

Tumor M2-PK: A novel urine marker of bladder cancer | PLOS ONE
Tumor M2-PK: A novel urine marker of bladder cancer | PLOS ONE

Diagnostics | Free Full-Text | Biomarkers for Bladder Cancer Diagnosis and  Surveillance: A Comprehensive Review | HTML
Diagnostics | Free Full-Text | Biomarkers for Bladder Cancer Diagnosis and Surveillance: A Comprehensive Review | HTML

Liquid biopsy in bladder cancer: State of the art and future perspectives -  ScienceDirect
Liquid biopsy in bladder cancer: State of the art and future perspectives - ScienceDirect

Use of Tumor Markers in Liver, Bladder, Cervical, Lung, and Gastric Cancers
Use of Tumor Markers in Liver, Bladder, Cervical, Lung, and Gastric Cancers

image8.jpg
image8.jpg

Risk Stratification for Bladder Tumor Recurrence, Stage and Grade by  Urinary Nuclear Matrix Protein 22 and Cytology - European Urology
Risk Stratification for Bladder Tumor Recurrence, Stage and Grade by Urinary Nuclear Matrix Protein 22 and Cytology - European Urology

Diagnostics | Free Full-Text | Biomarkers for Bladder Cancer Diagnosis and  Surveillance: A Comprehensive Review | HTML
Diagnostics | Free Full-Text | Biomarkers for Bladder Cancer Diagnosis and Surveillance: A Comprehensive Review | HTML